Back
Vanguard Total International Stock Index Fund ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
61
VXUS
Vanguard Total International Stock Index Fund ETF
Last Price:
$74.70
Seasonality Move:
1.27%
Sell
42
CRSP
CRISPR Therapeutics AG
Last Price:
$55.85
Seasonality Move:
14.46%
Buy
61
Vanguard Total International Stock Index Fund ETF (VXUS)
is a Buy
Is Vanguard Total International Stock Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Total International Stock Index Fund ETF [VXUS] share price is $75.57. The Score for VXUS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
VXUS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $54.84. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VXUS Stock Price Chart
What is Vanguard Total International Stock Index Fund ETF's stock price today?
-
The Vanguard Total International Stock Index Fund ETF share price today is $75.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VXUS is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $54.84The current trend is relatively stagnant and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
VXUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.65 | Buy |
| Relative Strength Index (14 RSI): | 55.72 | Buy |
| Chaikin Money Flow: | -3253536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.68 - 75.7) | Buy |
| Bollinger Bands (100): | (71.36 - 75.14) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 45.78 | Sell |
| Chaikin Money Flow: | -1252802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.68 - 56.94) | Buy |
| Bollinger Bands (100): | (52.47 - 65.41) | Sell |
VXUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.58 | Sell |
| 20-day SMA: | 74.84 | Buy |
| 50-day SMA: | 74.58 | Buy |
| 200-day SMA: | 69.37 | Buy |
| 8-day EMA: | 29.75 | Buy |
| 20-day EMA: | 13.66 | Buy |
| 50-day EMA: | 5.79 | Buy |
| 200-day EMA: | 1.49 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.4 | Sell |
| 20-day SMA: | 54.72 | Buy |
| 50-day SMA: | 59.34 | Sell |
| 200-day SMA: | 51.04 | Buy |
| 8-day EMA: | 55.77 | Sell |
| 20-day EMA: | 55.78 | Sell |
| 50-day EMA: | 56.38 | Sell |
| 200-day EMA: | 37.38 | Buy |
Vanguard Total International Stock Index Fund ETF Earnings Growth & VXUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Vanguard Total International Stock Index Fund ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||